Description: This report summarizes the results of a 2022 survey examining mortality improvement practices of life and annuity companies in the U.S. and Canada.

Description: This web page contains the 2011-2014 Group Annuity Experience Report and Pivot Tables.

Description: A short article looking at the results from an annual assumption survey of VA writers with a focus on changes companies observed and planned to make due to COVID-19. In the article we discuss what companies should be considering as they approach the 2020 year end assumption setting and audit season.

Description: This appendix II Report on the Life and Annuity Living Benefits Survey provides supplemental information for the Report on Life and Annuity Living Benefit Riders: Considerations for Insurers and Resinsurers. Appendix A gives a list of 34 participants and Appendix B provides a glossary of terms used in the report. The report utilizes a literature review, company survey, company interviews and/or other methods to catalog a listing of common living benefit riders. It was sponsored by the Product Development and Reinsurance Sections along with the Committee on Life Insurance Research.

Description: This web page contains the 2011-2014 Group Annuity Experience Report and Pivot Tables.

Description: This 1973 report is a sex-distinct summary of the relevant mortality experience for the general population, for insured lives, and for life annuitants.

Description: This web page contains the 2011-2014 Group Annuity Experience Report and Pivot Tables.

Description: 2020 and 2021 presented numerous challenges to life and annuity product development actuaries. External forces required carriers to rethink underwriting requirements and risk assessment in real time. Alterations in regulatory frameworks and statutory requirements forced changes to product development priorities while alterationsin the work environment forced changes in how work routines were structured. This session will bring together a group of life and annuity stakeholders to discuss how they addressed these and other challenges, and how their work will be impacted going forward.

Description: Historically different approaches have been used by actuaries in modeling mortality improvement. The SOA has recently released a framework that practitioners can use to project mortality improvement, providing methodological consistency across a range of applications.

Description: Discuss a comparison of the U.S. general and insured population mortality experience and how COVID-19 and non-COVID-19 excess deaths impacted the populations differently. Discover the population mortality experience in the UK with a focus on the recent emergence of excess deaths for non-COVID causes. The long-term implications on the insured population will also be explored. Wrap up with a discussion of different conditions of long COVID, including organ impairments.